CDK4/6 and PI3K inhibitors together have been shown to induce breast cancer cell apoptosis in vitro and suppress tumor growth in patient-derived tumor xenograft models (Herrera-Abreu et al., 2016). The gene discussed is PIK3CB; the disease is breast cancer.